Takeda Pharmaceutical Company Limited Stock Fukuoka Stock Exchange
Equities
4502
JP3463000004
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,080 JPY | -1.21% |
|
-.--% | +2.13% |
Sales 2024 | 4,264B 26.99B 36.98B | Sales 2025 * | 4,269B 27.03B 37.03B | Capitalization | 6,312B 39.96B 54.75B |
---|---|---|---|---|---|
Net income 2024 | 144B 912M 1.25B | Net income 2025 * | 103B 652M 894M | EV / Sales 2024 | 2.57 x |
Net Debt 2024 | 4,386B 27.77B 38.04B | Net Debt 2025 * | 4,189B 26.52B 36.33B | EV / Sales 2025 * | 2.46 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
62.2
x | Employees | - |
Yield 2024 |
4.49% | Yield 2025 * |
4.83% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 month | -5.01% | ||
Current year | +2.13% |
![Extreme 4080](/images/extremecours_fleche.png)
![Extreme 3175](/images/extremecours_fleche.png)
![Extreme 2990](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- 4502 Stock
- 4502 Stock